SAH Diagnostics has been named ‘Life Sciences Innovator of the Year’ at the 2026 Innovation Awards for transforming the cancer diagnosis and treatment pathway for NHS patients.
The honour recognises how the company has helped NHS trusts cut their waiting lists almost to zero by introducing faster and more efficient processes.
This is being achieved through ground-breaking methods, including the use of SAH Diagnostics’ mobile diagnostics and treatment units – coaches kitted out with state-of-the-art equipment, which brings additional consultant-led care directly to hospital sites.
Feroz Agad, chief executive of SAH Diagnostics, headquartered in Bristol, UK, said: “I am truly honoured to receive this award, which belongs to our clinicians, nurses and support teams, and to the NHS partners who trusted us to help.
“Behind every number on a waiting list is a patient and a family waiting for answers. Getting them those answers quickly is what drives us.”
Dr Richard Fallon, founder and chief executive of the Innovation Awards, said: “SAH Diagnostics is saving lives. It is improving patient experience and outcomes and delivering demonstrable improvements for the NHS, not least in making patient backlogs a thing of the past.
“This is exactly the kind of innovation these awards exist to celebrate, and Feroz and his team are thoroughly deserving winners.”
The award was presented to the SAH Diagnostics team at the 2026 Innovation Awards in Birmingham on November 13.
At Leicester Royal Infirmary, between 2022 and 2023, SAH Diagnostics helped turn University Hospitals of Leicester NHS Trust from one of the worst-performing trusts in the country for local anaesthetic transperineal (LATP) prostate biopsies and minor operations for suspected skin cancer into one of the best. Waits for urology patients fell from 16 weeks to three.
The work won SAH Diagnostics the HSJ Gold Award for the Most Effective Contribution to Improving Cancer Outcomes.
The company has delivered more than 400,000 procedures for over 30 NHS partners across England, including more than 15,000 LATP procedures.
Both the Leicester and Worcestershire trusts had been failing the 28-Day Faster Diagnosis Standard until SAH Diagnostics was brought in to help.
The standard requires patients to have cancer diagnosed or ruled out within 28 days of referral. SAH Diagnostics has since signed a deal with the West Midlands Cancer Alliance.
